GB1354269A - Pharmaceutical preparations - Google Patents
Pharmaceutical preparationsInfo
- Publication number
- GB1354269A GB1354269A GB701473A GB701473A GB1354269A GB 1354269 A GB1354269 A GB 1354269A GB 701473 A GB701473 A GB 701473A GB 701473 A GB701473 A GB 701473A GB 1354269 A GB1354269 A GB 1354269A
- Authority
- GB
- United Kingdom
- Prior art keywords
- feb
- compositions
- pharmaceutical preparations
- salt
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 abstract 1
- 101000653791 Bos taurus Protein S100-A12 Proteins 0.000 abstract 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 abstract 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 abstract 1
- 230000000648 anti-parkinson Effects 0.000 abstract 1
- 239000000939 antiparkinson agent Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003954 decarboxylase inhibitor Substances 0.000 abstract 1
- 229960002888 oxitriptan Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH207372 | 1972-02-14 | ||
| CH217172 | 1972-02-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1354269A true GB1354269A (en) | 1974-06-05 |
Family
ID=25689430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB701473A Expired GB1354269A (en) | 1972-02-14 | 1973-02-13 | Pharmaceutical preparations |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE2305209A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2181724B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1354269A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2180747A (en) * | 1985-09-20 | 1987-04-08 | Stephen Neil Kreitzman | Tryptophan composition for treatment of obesity |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH652025A5 (de) * | 1981-09-14 | 1985-10-31 | Hoffmann La Roche | Pharmazeutisches praeparat. |
| JPS5852219A (ja) * | 1981-09-22 | 1983-03-28 | Sumitomo Chem Co Ltd | パ−キンソン病治療剤 |
-
1973
- 1973-02-02 DE DE19732305209 patent/DE2305209A1/de active Pending
- 1973-02-13 FR FR7304987A patent/FR2181724B1/fr not_active Expired
- 1973-02-13 GB GB701473A patent/GB1354269A/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2180747A (en) * | 1985-09-20 | 1987-04-08 | Stephen Neil Kreitzman | Tryptophan composition for treatment of obesity |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2181724B1 (enrdf_load_stackoverflow) | 1975-10-10 |
| DE2305209A1 (de) | 1973-08-23 |
| FR2181724A1 (enrdf_load_stackoverflow) | 1973-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI822943A7 (fi) | Tromboksaanisyntetaasi-estoaineita, menetelmiä niiden valmistamiseksi sekä niitä sisältäviä farmaseuttisiayhdistelmiä. | |
| FI830752A7 (fi) | Karboksialkyylidipeptidit, niiden valmistusmenetelmät ja niitä sisältävät farmaseuttiset seokset. | |
| CA1006872A (en) | Enzymatic salt, the process for its preparation and therapeutical compositions which contain it | |
| AU468199B2 (en) | Pharmaceutical compositions containing cysteine derivatives | |
| GB1236670A (en) | Asparaginase having anti-tumor activity and process for preparing the same | |
| ATE69164T1 (de) | Arzneimittel zur behandlung von uraemie. | |
| FI822386A7 (fi) | Indoli-tromboksaanisyntetaasi- inhibiittoreita, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset. | |
| CA999805A (en) | Alloyed steel treatment with protein containing composition | |
| GB1354269A (en) | Pharmaceutical preparations | |
| GB1404614A (en) | Antibiotic a477 and process for preparation thereof | |
| GB1327560A (en) | Effervescent pharmaceutical preparations | |
| IL41259A0 (en) | Isoindoline derivatives,processes for their preparation and pharmaceutical compositions containing the same | |
| GB1393226A (en) | Therapeutic compositions and a process for the manufacture thereof | |
| NL164037B (nl) | Werkwijze ter bereiding van 1,4-dithiino- -2,3-cpyrrool-derivaten en van farmaceutische preparaten die deze derivaten bevatten. | |
| ES8506710A1 (es) | Procedimiento para la obtencion de teofilin-7-acetato de ambroxol | |
| GB1378296A (en) | Pharmaceutical composition | |
| JPS5270084A (en) | Polysaccharide ax | |
| CA953715A (en) | N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same | |
| GB1287433A (en) | Pharmaceutical compositions | |
| GB1250279A (enrdf_load_stackoverflow) | ||
| GB1272881A (en) | Composition containing s-carboxymethyl cysteine | |
| AU474214B2 (en) | Method of combating plant bacterial diseases, and composition for use inthe method | |
| CA1017357A (en) | N-(triaryl-methyl)-amidines, process for the preparation thereof and compositions containing the same | |
| CA945544A (en) | 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS | |
| GB1470393A (en) | Drug for the treatment of radiation sickness |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |